secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2026-08-03T21:01:56+00:00
Accession:  0001729149-26-000041
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viemed Q2 2026 revenue $78.1M record, up 23.9% YoY; raises FY revenue guidance
------------------------------------------------------------------------------

- Net revenue $78.1M (record), up 23.9% YoY; net income $2.8M ($0.07 diluted EPS).
- Adjusted EBITDA $13.7M, down 4% YoY due to prior-year non-recurring gain of $1.0M.
- Ventilator patients 12,635 (+4% YoY); PAP therapy patients 37,825 (+44% YoY).
- Repurchased 530,802 shares at avg $9.65 for $5.1M in Q2.
- FY 2026 revenue guidance raised to $314-320M (prev $312-320M); Adj. EBITDA guidance narrowed to $64-68M (prev $65-69M).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914926000041/0001729149-26-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914926000041/vmd-20260803.htm
  HTML page:      https://secwatch.observer/filing/0001729149-26-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer